Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Tourette Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Tourette Syndrome Key assessments Patient Segmentation in Tourette Syndrome Tourette Syndrome Risk & Burden Factors driving growth in a specific Tourette Syndrome patient population
January 2022
60 pages
Tourette Syndrome - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Syndrome Pipeline Analysis Tourette Syndrome Market Size and Trends Tourette Syndrome Market Opportunities Impact of upcoming Therapies in Tourette Syndrome Tourette Syndrome Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Unasyn - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Unasyn API intelligence over Unasyn and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Unisia (Amlodipine + Candesartan) - API Insight, 2022
US$ 500.00
... advantage by identifying the key patent expiry details with respect to Unisia (Amlodipine + Candesartan) API intelligence over Unisia (Amlodipine + Candesartan) and gaining primary intelligence over Active Ingredient manufacturers by country Make more ...
January 2022
30 pages
Varicose Veins - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Varicose Veins Key assessments Patient Segmentation in Varicose Veins Varicose Veins Risk & Burden Factors driving growth in a specific Varicose Veins patient population
January 2022
60 pages
Varicose Veins - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Veins Varicose Veins Pipeline Analysis Varicose Veins Market Size and Trends Varicose Veins Market Opportunities Impact of upcoming Therapies in Varicose Veins Varicose Veins Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2022
200 pages
Vasculitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Vasculitis Key assessments Patient Segmentation in Vasculitis Vasculitis Risk & Burden Factors driving growth in a specific Vasculitis patient population
January 2022
60 pages
Vasculitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Vasculitis Vasculitis Pipeline Analysis Vasculitis Market Size and Trends Vasculitis Market Opportunities Impact of upcoming Therapies in Vasculitis Vasculitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Vasculitis ...
January 2022
200 pages
Venous Thromboembolism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Venous Thromboembolism Key assessments Patient Segmentation in Venous Thromboembolism Venous Thromboembolism Risk & Burden Factors driving growth in a specific Venous Thromboembolism patient population
January 2022
60 pages
Venous Thromboembolism - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Venous Thromboembolism Report Assessment Current Treatment Practices in Venous Thromboembolism Unmet Needs in Venous Thromboembolism Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Von Willebrand Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Von Willebrand Disease Key assessments Patient Segmentation in Von Willebrand Disease Von Willebrand Disease Risk & Burden Factors driving growth in a specific Von Willebrand Disease patient population
January 2022
60 pages
Von Willebrand Disease - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Von Willebrand Disease Report Assessment Current Treatment Practices in Von Willebrand Disease Unmet Needs in Von Willebrand Disease Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2022
200 pages
Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Waldenstrom Macroglobulinemia Key assessments Patient Segmentation in Waldenstrom Macroglobulinemia Waldenstrom Macroglobulinemia Risk & Burden Factors driving growth in a specific Waldenstrom Macroglobulinemia patient population ...
January 2022
60 pages
Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Waldenstrom Macroglobulinemia Report Assessment Current Treatment Practices in Waldenstrom Macroglobulinemia Unmet Needs in Waldenstrom Macroglobulinemia Market Attractiveness Market Drivers and Barriers ...
January 2022
200 pages
Welchol - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Welchol API intelligence over Welchol and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Xerostomia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Xerostomia Key assessments Patient Segmentation in Xerostomia Xerostomia Risk & Burden Factors driving growth in a specific Xerostomia patient population
January 2022
60 pages
Xerostomia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Xerostomia Xerostomia Pipeline Analysis Xerostomia Market Size and Trends Xerostomia Market Opportunities Impact of upcoming Therapies in Xerostomia Xerostomia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Xerostomia ...
January 2022
200 pages
Yondelis - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Yondelis API intelligence over Yondelis and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Zerbaxa - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Zerbaxa API intelligence over Zerbaxa and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Insulin Resistance - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Insulin Resistance Key assessments Patient Segmentation in Insulin Resistance Insulin Resistance Risk & Burden Factors driving growth in a specific Insulin Resistance patient population
January 2022
60 pages
Pruritus - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Pruritus Key assessments Patient Segmentation in Pruritus Pruritus Risk & Burden Factors driving growth in a specific Pruritus patient population
January 2022
60 pages
Varicella Zoster (HHV-3) Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Varicella Zoster (HHV-3) Infections Key assessments Patient Segmentation in Varicella Zoster (HHV-3) Infections Varicella Zoster (HHV-3) Infections Risk & Burden Factors driving growth in a specific Varicella Zoster (HHV-3) Infections patient population
January 2022
60 pages
Bacterial Meningitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bacterial Meningitis Key assessments Patient Segmentation in Bacterial Meningitis Bacterial Meningitis Risk & Burden Factors driving growth in a specific Bacterial Meningitis patient population
January 2022
60 pages
Bacterial Meningitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Bacterial Meningitis Report Assessment Current Treatment Practices in Bacterial Meningitis Unmet Needs in Bacterial Meningitis Market Attractiveness Market Drivers and Barriers KEY ...
January 2022
200 pages
H3N2 Infection - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in H3N2 Infection Key assessments Patient Segmentation in H3N2 Infection H3N2 Infection Risk & Burden Factors driving growth in a specific H3N2 Infection patient population
January 2022
60 pages
Helicobacter Pylori Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Helicobacter Pylori Infections Key assessments Patient Segmentation in Helicobacter Pylori Infections Helicobacter Pylori Infections Risk & Burden Factors driving growth in a specific Helicobacter Pylori Infections patient ...
January 2022
60 pages
Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Hematopoietic Stem Cell Transplantation Key assessments Patient Segmentation in Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Transplantation Risk & Burden Factors driving growth in a specific Hematopoietic Stem Cell Transplantation patient population ...
January 2022
60 pages
Hemophilia B - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemophilia B Key assessments Patient Segmentation in Hemophilia B Hemophilia B Risk & Burden Factors driving growth in a specific Hemophilia B patient population
January 2022
60 pages
Hemostasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemostasis Key assessments Patient Segmentation in Hemostasis Hemostasis Risk & Burden Factors driving growth in a specific Hemostasis patient population
January 2022
60 pages
Hepatitis A - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hepatitis A Key assessments Patient Segmentation in Hepatitis A Hepatitis A Risk & Burden Factors driving growth in a specific Hepatitis A patient population
January 2022
60 pages
Hepatitis D - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast of Hepatitis D epidemiology 8MM Coverage Diagnosed Prevalent cases of Hepatitis D Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM Key assessments Patient Segmentation Disease Risk ...
January 2022
60 pages
Herpes Labialis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Herpes Labialis Key assessments Patient Segmentation in Herpes Labialis Herpes Labialis Risk & Burden Factors driving growth in a specific Herpes Labialis patient population
January 2022
60 pages
Ankylosing Spondylitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hospital Acquired Methicillin ...
January 2022
200 pages
Hot Flashes - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hot Flashes Key assessments Patient Segmentation in Hot Flashes Hot Flashes Risk & Burden Factors driving growth in a specific Hot Flashes patient population
January 2022
60 pages
Hyperkalemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperkalemia Key assessments Patient Segmentation in Hyperkalemia Hyperkalemia Risk & Burden Factors driving growth in a specific Hyperkalemia patient population
January 2022
60 pages
Hyperparathyroidism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperparathyroidism Key assessments Patient Segmentation in Hyperparathyroidism Hyperparathyroidism Risk & Burden Factors driving growth in a specific Hyperparathyroidism patient population
January 2022
60 pages
Hyperphosphatemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperphosphatemia Key assessments Patient Segmentation in Hyperphosphatemia Hyperphosphatemia Risk & Burden Factors driving growth in a specific Hyperphosphatemia patient population
January 2022
60 pages
Hypersomnia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypersomnia Key assessments Patient Segmentation in Hypersomnia Hypersomnia Risk & Burden Factors driving growth in a specific Hypersomnia patient population
January 2022
60 pages
Hypertriglyceridemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypertriglyceridemia Key assessments Patient Segmentation in Hypertriglyceridemia Hypertriglyceridemia Risk & Burden Factors driving growth in a specific Hypertriglyceridemia patient population
January 2022
60 pages
Hyperuricemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperuricemia Key assessments Patient Segmentation in Hyperuricemia Hyperuricemia Risk & Burden Factors driving growth in a specific Hyperuricemia patient population
January 2022
60 pages
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Pulmonary Fibrosis Key assessments Patient Segmentation in Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis Risk & Burden Factors driving growth in a specific Idiopathic Pulmonary Fibrosis patient population ...
January 2022
60 pages
Idiopathic Short Stature - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Short Stature Key assessments Patient Segmentation in Idiopathic Short Stature Idiopathic Short Stature Risk & Burden Factors driving growth in a specific Idiopathic Short Stature patient population
January 2022
60 pages
Idiopathic Thrombocytopenic Purpura - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Thrombocytopenic Purpura Key assessments Patient Segmentation in Idiopathic Thrombocytopenic Purpura Idiopathic Thrombocytopenic Purpura Risk & Burden Factors driving growth in a specific Idiopathic Thrombocytopenic Purpura patient population
January 2022
60 pages
Impetigo - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Impetigo Key assessments Patient Segmentation in Impetigo Impetigo Risk & Burden Factors driving growth in a specific Impetigo patient population
January 2022
60 pages
Indolent Lymphoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Indolent Lymphoma Key assessments Patient Segmentation in Indolent Lymphoma Indolent Lymphoma Risk & Burden Factors driving growth in a specific Indolent Lymphoma patient population
January 2022
60 pages
Infantile Spasm - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Infantile Spasm Key assessments Patient Segmentation in Infantile Spasm Infantile Spasm Risk & Burden Factors driving growth in a specific Infantile Spasm patient population
January 2022
60 pages
Influenza A Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Influenza A Infections Key assessments Patient Segmentation in Influenza A Infections Influenza A Infections Risk & Burden Factors driving growth in a specific Influenza A Infections patient population
January 2022
60 pages
Intermittent Claudication - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Intermittent Claudication Key assessments Patient Segmentation in Intermittent Claudication Intermittent Claudication Risk & Burden Factors driving growth in a specific Intermittent Claudication patient population
January 2022
60 pages
Iron Deficiency Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Iron Deficiency Anemia Key assessments Patient Segmentation in Iron Deficiency Anemia Iron Deficiency Anemia Risk & Burden Factors driving growth in a specific Iron Deficiency Anemia patient population
January 2022
60 pages
